Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 8/20 | 0.72 |
| ▸ | MAPT | P10636 | 4/20 | 0.72 |
| ▸ | MEN1 | O00255 | 4/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.72 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.72 |
| ▸ | HTT | P42858 | 2/20 | 0.72 |
| ▸ | HPGD | P15428 | 2/20 | 0.72 |
| ▸ | RECQL | P46063 | 2/20 | 0.72 |
| ▸ | BLM | P54132 | 2/20 | 0.72 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.72 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.72 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.72 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.72 |
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | USP2 | O75604 | 2/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.57 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.52 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31005263 | 0.93 | FTO (0.63) | FTOMAPTMEN1KMT2ATDP1 | |
| Fluorescein SCHEMBL20822420 | 0.89 | FTO (0.79) | FTOMAPTMEN1KMT2ATDP1 | |
| Fluorescein SCHEMBL27464110 | 0.89 | FTO (0.87) | FTOMAPTMEN1KMT2ATDP1 | |
| SCHEMBL5586209 | 0.87 | FTO (0.55) | FTOMAPTMEN1KMT2ATDP1 | |
| SCHEMBL7210796 | 0.86 | FTO (0.79) | FTOMAPTMEN1KMT2ATDP1 | |
| SCHEMBL4663321 | 0.86 | FTO (0.82) | FTOMAPTMEN1KMT2ATDP1 | |
| SCHEMBL113888 | 0.86 | FTO (0.52) | FTOMAPTMEN1KMT2ATDP1 | |
| SCHEMBL7740798 | 0.85 | FTO (0.81) | FTOMAPTMEN1KMT2ATDP1 | |
| Fluorescein SCHEMBL27874481 | 0.85 | FTO (0.81) | FTOMAPTMEN1KMT2ATDP1 | |
| Fluorescein SCHEMBL1198361 | 0.85 | FTO (0.94) | FTOMAPTMEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 817 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250171830-A1 | NUCLEIC ACID PROBES FOR IN SITU HYBRIDIZATION | ENZO BIOCHEM INC (US) | 2025-05-29 | — | — | US | claimed |
| CN-109863161-B | Labeled polynucleotides useful for nucleic acid sequencing | 豪夫迈·罗氏有限公司 | 2022-06-03 | — | — | CN | claimed |
| US-10041117-B2 | Primers and methods for the detection and discrimination of nucleic acids | Life Technologies Corporation (US) | 2018-08-07 | — | — | US | claimed |
| WO-2017068087-A1 | OLIGONUCLEOTIDE DETECTION METHOD | ROCHE INNOVATION CENTER COPENHAGEN A/S (DK) | 2017-04-27 | — | — | WO | claimed |
| US-20260085087-A1 | CHEMICAL COMPOUND COMPRISING A TRIAZINE GROUP AND METHOD FOR PRODUCING SAME | KUPRYUSHKIN MAXIM SERGEEVICH (RU) | 2026-03-26 | — | — | US | disclosed |
| US-20250320554-A1 | Asymmetric Rhodamine Dye and Use Thereof in Biological Assays | LIFE TECHNOLOGIES CORP (US) | 2025-10-16 | — | — | US | disclosed |
| EP-4623104-A1 | METHODS FOR DETECTING DIASTATIC YEAST CONTAMINANTS | Invisible Sentinel, Inc. (US) | 2025-10-01 | — | — | EP | disclosed |
| EP-4623108-A2 | METHODS FOR DETECTING ALICYCLOBACILLUS CONTAMINANTS | Invisible Sentinel, Inc. (US) | 2025-10-01 | — | — | EP | disclosed |
| US-12415828-B2 | Modified oligonucleotides and methods for their synthesis | NOOGEN LLC (RU) | 2025-09-16 | — | — | US | disclosed |
| US-12415835-B2 | Peptide-compound cyclization method | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-09-16 | — | — | US | disclosed |
| US-12410181-B2 | Modified rhodamine dye and use thereof in biological assays | Life Technologies Corporation (US) | 2025-09-09 | — | — | US | disclosed |
| EP-4602169-A2 | NOVEL ANTISENSE HYBRID MORPHOLINO OLIGONUCLEOTIDES AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2025-08-20 | — | — | EP | disclosed |
| EP-0527184-B1 | PHOSPHORAMIDITE DERIVATIVES, THEIR PREPARATION AND THE USE THEREOF IN THE INCORPORATION OF REPORTER GROUPS ON SYNTHETIC OLIGONUCLEOTIDES | AMERSHAM INT PLC (GB) | 1995-08-02 | — | — | EP | disclosed |
| WO-1995018136-A1 | BACKBONE MODIFIED OLIGONUCLEOTIDE ANALOGS AND SOLID PHASE SYNTHESIS THEREOF | ISIS PHARMACEUTICALS, INC. (US) | 1995-07-06 | — | — | WO | disclosed |
| EP-0642592-A1 | LIGASE CHAIN REACTION STARTING WITH RNA SEQUENCES | ABBOTT LABORATORIES (US) | 1995-03-15 | — | — | EP | disclosed |
| WO-1994008053-A1 | OLIGONUCLEOTIDES HAVING A CONSERVED G4 CORE SEQUENCE | ISIS PHARMACEUTICALS, INC. (US) | 1994-04-14 | — | — | WO | disclosed |
| WO-1993024656-A1 | LIGASE CHAIN REACTION STARTING WITH RNA SEQUENCES | ABBOTT LABORATORIES (US) | 1993-12-09 | — | — | WO | disclosed |
| WO-1993020240-A1 | METHOD AND DEVICE FOR DETECTION OF NUCLEIC ACID OR ANALYTE USING TOTAL INTERNAL REFLECTANCE | ABBOTT LABORATORIES (US) | 1993-10-14 | — | — | WO | disclosed |
| EP-0527184-A1 | PHOSPHORAMIDITE DERIVATIVES, THEIR PREPARATION AND THE USE THEREOF IN THE INCORPORATION OF REPORTER GROUPS ON SYNTHETIC OLIGONUCLEOTIDES. | AMERSHAM INT PLC (GB) | 1993-02-17 | — | — | EP | disclosed |
| WO-1991017169-A1 | PHOSPHORAMIDITE DERIVATIVES, THEIR PREPARATION AND THE USE THEREOF IN THE INCORPORATION OF REPORTER GROUPS ON SYNTHETIC OLIGONUCLEOTIDES | AMERSHAM INTERNATIONAL PLC (GB) | 1991-11-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260085087-A1 | CHEMICAL COMPOUND COMPRISING A TRIAZINE GROUP AND METHOD FOR PRODUCING SAME | NSUN2, POLM, SSU72 | FTO 280/4885MAPT 4316/4885MEN1 4720/4885 |
| US-12415828-B2 | Modified oligonucleotides and methods for their synthesis | RNGTT, TYMP, POLM | FTO 1583/4885MAPT 4542/4885MEN1 2397/4885 |
| US-12410181-B2 | Modified rhodamine dye and use thereof in biological assays | QTRT1, MRPL21, RRP1B | FTO 2458/4885MAPT 3356/4885MEN1 3062/4885 |
| US-20250320554-A1 | Asymmetric Rhodamine Dye and Use Thereof in Biological Assays | HNRNPR, HNRNPH3, LYAR | FTO 3132/4885MAPT 4547/4885MEN1 2964/4885 |
| US-12415835-B2 | Peptide-compound cyclization method | VIP, NGLY1, GLP1R | FTO 4850/4885MAPT 3614/4885MEN1 394/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.